Compare
Enovis Corp vs MSA Safety Inc vs Align Technology Inc vs Edwards Lifesciences Corp
| Latest fiscal year | Enovis Corp ENOV | MSA Safety Inc MSA | Align Technology Inc ALGN | Edwards Lifesciences Corp EW |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $2.25B | $1.87B | $4.03B | $6.07B |
| Revenue growth (YoY) | +6.7% | +3.7% | +0.9% | +11.5% |
| Gross margin | 59.8% | 46.5% | 67.2% | 78.0% |
| Operating margin | -50.0% | 19.8% | 13.5% | 20.8% |
| Net margin | -52.7% | 14.9% | 10.2% | 17.6% |
| Net income | -$1.18B | $278.92M | $410.35M | $1.07B |
| EPS (Diluted) | -$20.75 | $7.09 | $5.65 | $1.83 |
| Operating cash flow | $217.29M | $363.87M | $593.22M | $1.60B |
| Free cash flow | $19.92M | $295.43M | $490.78M | $1.33B |
| Cash & equivalents | $36.39M | $165.07M | $1.09B | $2.94B |
| Total assets | $3.83B | $2.55B | $6.23B | $13.70B |
| Total liabilities | $2.34B | $1.19B | $2.18B | $3.36B |
| Shareholders' equity | $1.49B | $1.37B | $4.05B | $10.34B |
| Return on year-end equity | -79.5% | 20.4% | 10.1% | 10.3% |
| Shares outstanding | 57.19M | 38.91M | 71.36M | 580.70M |
Revenue, most recent five fiscal years
| Fiscal year | Enovis Corp | MSA Safety Inc | Align Technology Inc | Edwards Lifesciences Corp |
|---|---|---|---|---|
| Latest | $2.25B Ended 2025-12-31 | $1.87B Ended 2025-12-31 | $4.03B Ended 2025-12-31 | $6.07B Ended 2025-12-31 |
| 1 year earlier | $2.11B Ended 2024-12-31 | $1.81B Ended 2024-12-31 | $4.00B Ended 2024-12-31 | $5.44B Ended 2024-12-31 |
| 2 years earlier | $1.71B Ended 2023-12-31 | $1.79B Ended 2023-12-31 | $3.86B Ended 2023-12-31 | $5.01B Ended 2023-12-31 |
| 3 years earlier | $1.56B Ended 2022-12-31 | $1.53B Ended 2022-12-31 | $3.73B Ended 2022-12-31 | $4.46B Ended 2022-12-31 |
| 4 years earlier | $1.43B Ended 2021-12-31 | $1.40B Ended 2021-12-31 | $3.95B Ended 2021-12-31 | $5.23B Ended 2021-12-31 |